Evidence map›Paper›PMID 40872607›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Network Pharmacology and Experiment Verification-Based Strategy for Exploring the Mechanisms of Shuqing Granule in the Treatment of COVID-19.

Xiaoping Guo, Haoyu Zheng, Yiming An, Yuemeng Song, Tianqi Liu, Zhengjie Zhou, Chuangui Liu, Guoqiang Wang, Fang Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaoping GuoDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Haoyu ZhengDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Yiming AnDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Yuemeng SongDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Tianqi LiuDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Zhengjie ZhouDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Chuangui LiuNational and Local United Engineering R&D Center of Ginseng Innovative Drugs, Changchun 130021, China.
Guoqiang WangDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Fang WangDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.ORCID 0000-0003-0871-3454

Funding

Jilin Provincial Department of Education Science and Technology Research Planning Project JJKH20211160KJJilin Provincial Science and Technology Innovation Center of Secondary Development of Chinese Traditional Patent Medicine 20210502005ZPJilin Provincial Science and Technology Planning Program 20200901004SFKey Laboratory of Precision Infectious Diseases of Jilin Province 20200601011JCthe Jilin Province Innovation and Entrepreneurship Talent Funding Project 2020017
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACE2molecular dockingSARS-CoV-2traditional Chinese medicine

Identifiers

PMID40872607
PMCPMC12389595

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.